2026 Q3 Portfolio Activity
In 2026 Q3, Krensavage Asset Management, LLC maintained a portfolio of 21 distinct positions. The most significant new addition was ANI PHARMACEUTICALS INC, now representing 0.36% of the total fund value. They heavily accumulated shares in ULTRAGENYX PHARMACEUTICAL IN, increasing the position by 191.9%. Conversely, Krensavage Asset Management, LLC completely exited their position in REGENERON PHARMACEUTICALS.
Position History
hover any row below to update
Loading…
Total Positions
21
Quarter
2026 Q3
Top Holding
JAZZ (14.6%)
Top 10 Concentration
88.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-21 of 21
Krensavage Asset Management, LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 14.64% | 15.36% |
#1
1
Prev: #2
|
7.0 |
—
|
no change | no change |
P
S
|
167,816 | $38,853 |
$116.23
+109.7%
|
2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-17 | ||
|
ENTA
ENANTA PHARMACE...
|
Healthcare | 14.23% | 15.88% |
#2
1
Prev: #1
|
6.5 |
—
|
no change | no change |
P
S
|
2,866,138 | $37,776 | 2015 Q1 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 13.53% | 14.26% |
#3
Prev: #3
|
5.5 |
—
|
-3,000 | -4.3% |
P
S
|
66,282 | $35,918 | 2014 Q4 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 11.86% | 11.41% |
#4
Prev: #4
|
5.5 |
—
|
no change | no change |
P
S
|
524,786 | $31,487 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
ABT
ABBOTT LABORATO...
|
Healthcare | 7.45% | 6.89% |
#5
1
Prev: #6
|
4.5 |
—
|
no change | no change |
P
S
|
200,000 | $19,766 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
EXEL
EXELIXIS INC
|
Healthcare | 6.59% | 7.66% |
#6
1
Prev: #5
|
3.1 |
—
|
-71,300 | -19.2% |
P
S
|
299,393 | $17,488 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 6.46% | 4.96% |
#7
2
Prev: #9
|
5.6 |
—
|
749,988 | 191.9% |
P
S
|
1,140,867 | $17,147 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
SUPN
SUPERNUS PHARMA...
|
Healthcare | 5.69% | 4.96% |
#8
Prev: #8
|
4.8 |
—
|
70,000 | 24.9% |
P
S
|
350,681 | $15,093 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
SNY
SANOFI-ADR
|
Healthcare | 5.19% | 5.25% |
#9
2
Prev: #7
|
2.6 |
—
|
10,000 | 3.1% |
P
S
|
333,946 | $13,769 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
EMBC
EMBECTA CORP
|
Healthcare | 2.42% | 1.41% |
#10
5
Prev: #15
|
2.0 |
—
|
no change | no change |
P
S
|
1,135,340 | $6,426 | 2022 Q2 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 2.34% | 1.04% |
#11
5
Prev: #16
|
3.9 |
—
|
1,280,969 | 239.6% |
P
S
|
1,815,492 | $6,209 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
BNTX
BIONTECH SE-ADR
|
Healthcare | 2.20% | 2.10% |
#12
1
Prev: #11
|
1.9 |
—
|
no change | no change |
P
S
|
59,523 | $5,851 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
VNDA
VANDA PHARMACEU...
|
Healthcare | 2.18% | 2.74% |
#13
3
Prev: #10
|
1.9 |
—
|
no change | no change |
P
S
|
1,180,388 | $5,796 | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
GSK
GSK PLC-SPON AD...
|
Healthcare | 1.76% | 1.93% |
#14
2
Prev: #12
|
1.7 |
—
|
no change | no change |
P
S
|
96,729 | $4,659 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 1.70% | 1.64% |
#15
2
Prev: #13
|
1.7 |
—
|
no change | no change |
P
S
|
20,000 | $4,518 | 2019 Q1 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
INMD
INMODE LTD
|
Healthcare | 0.65% | 0.67% |
#16
1
Prev: #17
|
1.3 |
—
|
no change | no change |
P
S
|
120,942 | $1,714 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
ANIP
ANI PHARMACEUTI...
|
Healthcare | 0.36% | — |
#17
Prev: #—
|
3.6 |
—
|
13,000 | — |
NEW
|
13,000 | $944 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 0.30% | — |
#18
Prev: #—
|
3.6 |
—
|
40,000 | — |
NEW
|
40,000 | $806 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
ZTS
ZOETIS INC
|
Healthcare | 0.26% | — |
#19
Prev: #—
|
3.6 |
—
|
10,000 | — |
NEW
|
10,000 | $698 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
EOLS
EVOLUS INC
|
Healthcare | 0.17% | 0.42% |
#20
2
Prev: #18
|
0.1 |
—
|
-100,000 | -63.3% |
P
S
|
57,985 | $464 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-17 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 0.00% | 1.42% |
Sold All 😨
(Was: #14) |
0.0 |
—
|
-6,000 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-17 |
Showing 1-21 of 21 holdings